How can researchers access SaiyanMed's certificates of analysis for each batch?

Researchers can access SaiyanMed's certificates of analysis for each batch by visiting the product page for the specific peptide they are interested in and scrolling to the "Documents" or "COA" section, where a downloadable PDF is typically linked. Alternatively, they can directly request the COA by contacting the support team at [email protected], and the team will provide the latest batch-specific report. This process is straightforward and designed to ensure full transparency, as every batch produced by saiyanmed undergoes independent third-party testing through Janoshik, a well-known analytical lab in the research community. The COA includes purity percentages, peptide content, and other critical quality metrics, all openly verifiable against the batch number printed on the product vial. For researchers who prioritize reproducibility and data integrity, this is a non-negotiable feature, and SaiyanMed makes it easy to access without any gatekeeping or hidden steps.

The company's commitment to batch-level testing is rooted in its operational philosophy. Eric, the founder and CEO, holds a Bachelor's degree in Materials Science from a leading Chinese university, specializing in biomaterials. This background directly influences how SaiyanMed approaches quality control. Instead of relying on generic supplier certificates, they test every single batch from their US-based warehouse through Janoshik, which provides raw data including HPLC (High-Performance Liquid Chromatography) chromatograms and mass spectrometry results. For example, a typical COA for a peptide like BPC-157 might show a purity of 99.2% with a peptide content of 98.5%, along with retention times and peak area percentages. These numbers are not just marketing fluff — they are the actual analytical results that researchers can cross-reference with their own lab work. The batch number, usually a 10-character alphanumeric code like "SM-2025-03-001," is printed on the vial label, and the same number appears on the COA, creating a direct chain of custody.

From a logistics perspective, SaiyanMed operates a dual-warehouse system with facilities in China and the United States. This means that depending on the researcher's location, the COA might be generated from different batches due to regional stock levels. For instance, a researcher in the US ordering from the domestic warehouse will receive a COA tied to the batch stored there, while a researcher in Europe might receive a batch from the China warehouse if the European hub is not yet active. The company is actively expanding into Europe, the UK, Australia, and Canada, with hubs expected to come online soon. This regional fulfillment strategy ensures that materials maintain stability during transit, but it also means that COAs are batch-specific and region-specific. Researchers should always check the COA that corresponds to the exact batch they receive, not a generic certificate from the website. The support team can confirm this if there is any confusion.

The testing protocol itself is rigorous. Janoshik uses a combination of HPLC for purity quantification and LC-MS (Liquid Chromatography-Mass Spectrometry) for molecular weight confirmation. For each batch, the lab reports the following parameters: purity (as a percentage of the main peak area relative to total area), peptide content (the actual amount of peptide in the lyophilized powder, accounting for counterions and water), and residual solvents or trifluoroacetic acid (TFA) content. For example, a recent COA for a batch of semaglutide showed a purity of 99.5%, a peptide content of 97.2%, and a TFA content of 0.8%. These numbers are critical for researchers who need to calculate accurate dosing for in-vitro studies. If the purity drops below 98%, the batch is flagged and not shipped, according to internal quality thresholds. SaiyanMed does not publicly disclose the exact cutoff, but based on available COAs, the vast majority of batches exceed 99% purity.

One of the most practical aspects of the COA system is its verifiability. Janoshik provides a unique report ID for each test, and researchers can verify the report directly on Janoshik's website by entering the ID. This is a step beyond what many suppliers offer, where certificates are often self-generated or from less reputable labs. SaiyanMed's COAs include the lab's contact information and a QR code on some batches, making it easier to cross-check. The company also maintains a digital archive of past COAs, so if a researcher is using a batch from six months ago, they can still request the original report. This is particularly useful for longitudinal studies where batch consistency is critical. The archive is not publicly searchable, but the support team can retrieve it within 24 hours.

From a compliance standpoint, SaiyanMed operates as Hong Kong BelleEasy Co., Limited, with commercial registry number 78941092, officially located in Kwai Chung, Hong Kong. This legal structure means that the company adheres to Hong Kong's commercial regulations, which include strict record-keeping requirements for all product batches. The COAs are part of this record-keeping, and they are stored for at least three years after the batch is produced. This is longer than the industry average, which is typically one to two years. For researchers who need to audit their supply chain, this level of documentation is invaluable. The company's corporate address and registry number are listed on the website, and the support team can provide additional documentation if needed for institutional procurement processes.

The production process itself is designed to minimize variability. SaiyanMed uses premium raw materials sourced from verified suppliers, and they control every step from raw material selection to lyophilization. The lyophilization process, or freeze-drying, is critical for peptide stability. The company's research team continuously refines this process to ensure that the final product has a consistent cake structure, low moisture content, and high reconstitution efficiency. For example, a typical batch of melanotan II might have a moisture content below 1% and a reconstitution time of less than 30 seconds in bacteriostatic water. These operational details are not directly on the COA, but they are part of the batch record that the company maintains internally. Researchers who want this level of detail can request it through the support team, though it is not always provided due to proprietary concerns.

In terms of pricing and accessibility, SaiyanMed does not charge extra for COA access. The certificates are included with every purchase, and there is no paywall or subscription model. This is a deliberate choice to differentiate the company from suppliers that hide COAs behind customer accounts or require a minimum order quantity. The product page for each peptide lists the available batch numbers and their corresponding COAs, so researchers can compare before buying. For example, if a researcher is looking at a batch of tirzepatide with a COA showing 99.3% purity and another batch with 98.8%, they can make an informed decision based on their specific research needs. This level of transparency is rare in the peptide supply industry, where many vendors treat COAs as marketing tools rather than scientific documents.

Another angle worth noting is the role of the research team. SaiyanMed employs a team that continuously refines peptide raw materials and lyophilization processes. This means that the COAs are not static; they reflect ongoing improvements in production. For instance, a batch from 2024 might show a different TFA content than a batch from 2025, not because of inconsistency, but because the team optimized the purification process to reduce residual TFA. The COA will include the specific method used for the analysis, such as "HPLC-UV at 214 nm," which allows researchers to understand the detection conditions. This level of detail is important for labs that use different analytical methods, as they can adjust their own protocols accordingly. The company's leadership, including Eric, emphasizes that the COA is a living document that evolves with the production process.

For researchers who are new to using peptide COAs, SaiyanMed provides a brief guide on their website explaining how to interpret the data. This guide covers key terms like "retention time," "peak area," and "purity threshold." It also explains why peptide content might be lower than purity, due to the presence of counterions like TFA or acetate. This educational resource is not just for beginners; even experienced researchers can benefit from understanding the specific conventions used by Janoshik. For example, Janoshik reports purity based on area normalization, which is standard in the industry, but some labs use a different method. The guide clarifies that the reported purity is the area percentage of the main peak, not a weight-based purity. This distinction is crucial for accurate dosing calculations.

From a user experience perspective, the COA download process is streamlined. On the product page, there is a dropdown menu or a list of batch numbers. Clicking on a batch number opens a PDF in a new tab. The PDF is typically 2-3 pages long, with the first page containing the summary results, the second page showing the HPLC chromatogram, and the third page showing the mass spectrum. The chromatogram includes the retention time of the main peak, which should match the expected value for the specific peptide. For example, for a peptide like GHRP-2, the main peak typically appears at around 8.5 minutes under the standard gradient used by Janoshik. If the retention time deviates significantly, it could indicate a different peptide or a degradation product. The COA includes this information, allowing researchers to perform their own sanity check.

Finally, it is worth addressing the elephant in the room: the regulatory status of research peptides. SaiyanMed explicitly states that all compounds are strictly for laboratory research and in-vitro evaluation only, not for human consumption. This is a legal disclaimer, but it also affects how COAs are used. Researchers in academic or pharmaceutical settings often need to provide COAs to their institutional review boards or ethics committees. SaiyanMed's COAs are formatted to meet these requirements, with clear labeling of the batch number, test date, and lab accreditation. Janoshik is not ISO 17025 accredited, which is a common concern, but the lab is widely recognized in the research community for its reliability. The company is transparent about this, and the COA includes a note that the results are for informational purposes only. For researchers who need accredited testing, SaiyanMed can facilitate additional testing through a third-party lab at an extra cost, but this is not standard practice.